Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
10 Jul 2019 Night Shift Work Classified as Probably Carcinogenic to Humans Epidemiology/Etiology/Cancer Prevention
09 Jul 2019 Molecular Characterisation of Non-functional Pancreatic Neuroendocrine Tumours Endocrine and neuroendocrine tumours - Translational research
08 Jul 2019 EMA Recommends Extension of Indications for Ibrutinib Haematologic malignancies - Anticancer agents & Biologic therapy
05 Jul 2019 FDA Approves Daratumumab for Multiple Myeloma Ineligible for Autologous Stem Cell Transplant Haematologic malignancies - Anticancer agents & Biologic therapy
04 Jul 2019 Informed Consent Application for Azacitidine Celgene Received a Positive Opinion from the EMA Haematologic malignancies - Anticancer agents & Biologic therapy
03 Jul 2019 Daratumumab Shows Clinical Benefit in Combination With Standard of Care in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Jul 2019 Population-level Impact of HPV Vaccination Gynaecologic malignancies - Epidemiology/Etiology/Cancer Prevention
01 Jul 2019 EMA Recommends Extension of Indications for Ramucirumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Jun 2019 EMA Recommends Extension of Indications for Atezolizumab Breast cancer - Cancer Immunology and Immunotherapy
27 Jun 2019 Molecular Profiling in Routine Practice for Advanced Cancers Personalised medicine
26 Jun 2019 Japan Becomes the First Country to Approve Entrectinib Personalised medicine - Anticancer agents & Biologic therapy
25 Jun 2019 Clinical Utility of Neoadjuvant Immune Checkpoint Inhibitors in Resectable NSCLC Remains Unknown Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
24 Jun 2019 Which Neoadjuvant Treatment Strategy for High-Risk Resectable Melanoma? Melanoma and other skin tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
21 Jun 2019 BLU-667 in RET-driven NSCLC and Thyroid Cancer Lung and other thoracic tumours - Endocrine and neuroendocrine tumours - Personalised medicine - Anticancer agents & Biologic therapy
19 Jun 2019 FDA Approves Pembrolizumab for Metastatic Small Cell Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy